causal

Surrogate Endpoints Speed Drug Development

A surrogate is a biomarker such as tumor shrinkage that predicts clinical benefit, and validated surrogates let developers decide to continue or discontinue a drug in years rather than waiting five to ten years for survival outcomes, which is why government agencies should invest heavily in finding them.

causalpending

Speaker

Alex

Evidence Quote

“as soon as you have an established surrogate that the regulators can use, you really speed up how quickly you can iterate on developing drugs.”

Source

Alex Telford - Unlocking Innovation in Pharma - [Invest Like the Best, EP.360]— Invest Like the Best
Created: 11/14/2026, 6:42:06 AM

Your notes

Loading notes...